We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Recipharm Acquires OnTarget Chemistry

News   Jun 16, 2015

 
Recipharm Acquires OnTarget Chemistry
 
 
Advertisement
 

RELATED ARTICLES

Novel Inhibitor Shown To Combat Drug-Resistant Tumor Cells

News

A team of researchers from Martin Luther University Halle-Wittenberg and the University of Greifswald has developed a new inhibitor of multi-drug resistant protein 4 (MRP4). When the inhibitor was tested on drug-resistant cancer cell lines, the cancer cells began to respond to chemotherapy.

READ MORE

Tailoring Botox Proteases To Target New Proteins

News

A team of researchers has demonstrated that it is possible to rapidly evolve botulinum toxin in the laboratory to target a variety of different proteins.

READ MORE

New Method for Asymmetric N,N-Acetal Synthesis Set To Aid Drug Development

News

A lot of medicines and other bioactive drugs are based on chemical structures called "enantiomers", among them are chiral N,N-acetals. A new study presents the first highly stereoselective formation of chiral N,N-acetals from α-ketoesters using an original catalyst.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE